Sangamo Therapeutics (SGMO)

$0.11 -0.07 (-37.27%)
Market Cap 73.58M
Revenue (ttm) 39.55M
Net Income (ttm) -122.93M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -310.82%
Debt to Equity Ratio 0.00
Volume 44,541,699
Avg Vol 10,731,998
Day's Range N/A - N/A
Shares Out 414.28M
Stochastic %K 4%
Beta 1.04
Analysts Sell
Price Target $3.75

Company Profile

Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States. The company's clinical-stage product candidates are ST-920, a gene therapy product candidate, which is in Phase 1/2 clinical study for the treatment of Fabry disease; small fiber neuropathy for chronic neuropathic pain, and prion disease; Phase 1/2 clinical trial to evaluate the...

Industry: Biotechnology
Sector: Healthcare
Phone: 510 970 6000
Address:
501 Canal Blvd, Richmond, United States
Herr_Chicken
Herr_Chicken Jun. 29 at 2:54 AM
$SGMO Listened to the whole First Day hearing tape yesterday; some things that hit me: 1. Even in bankruptcy, Sangamo is being a drama queen. It's amazing. They wanted the judge to approve their sale procedures by June 30 (!), before the creditor's committee is even formed. They are completely out of cash on June 30, if I heard correctly. The attorney for the US Trustee was freaking about all this happening before she could get the creditor's committee together and also freaking about the DIP financer's motion to get its entire fee approved on Day 1 of the bankruptcy, calling it unprecedented on both counts. There were real problems about due process to creditors and other interested parties. The judge had problems with both those things too, so now we have a hearing on the bid procedures by mid-month (i.e., after creditors committee organizes) and the judge approved the DIP financer but only made fee on the first 10.5 mill final. (cont. in replies)
3 · Reply
Scooter0732
Scooter0732 Jun. 29 at 1:53 AM
$SGMO What I found interesting was the attorney for Lilly made it a condition precedent to the APA that the auction be held on Aug 4th. They want to shorten the DD period which is their strongest lever to suppress bidding. In a sense that’s cool that they care enough to want to steal it, but this kind of maneuver will not work if there’s a party mid-DD the board overseeing the bankruptcy estate will stretch the timeline a bit to allow them to participate, if there is such a party. The judge was non-committal and punted on the issue, the picture will become clearer after indicate bids are submitted in July.
1 · Reply
Scooter0732
Scooter0732 Jun. 29 at 1:31 AM
$SGMO FSI is merely a DIP lender who wanted to take the operating losses in the holdco to merge it with some other profitable business to take advantage of NOL. They wouldn’t buy any other assets. SGMO is getting liquidated anyway. This is literally irrelevant to anything and in the end they were rejected and Sangamo chose the other lender. It might prevent SGMO from merging or being wholly aquired so it’s cleaner to just to get a DIP lender in it for some interest, so the board overseeing the bankruptcy made the right call.
0 · Reply
pblegend66
pblegend66 Jun. 29 at 1:08 AM
@jlemx $SGMO That last part is what terrifies me. They are trying to go the loan-to-own strategy because they are scum. FSI is trying to use debt to wipe out all existing shareholders. This is a typical tactic in these Chapter 11's. It makes sure people who own the debt will make off with all the equity and leave common shareholders holding the bag. This sort of stuff should be illegal. FSI just has to convince the creditors because they hold all the cards. And they usually go along with it because they are cut in on the deal. Freakin shameful.
0 · Reply
pblegend66
pblegend66 Jun. 29 at 12:59 AM
@jlemx $SGMO That last part is what terrifies me. They are trying to go the loan-to-own strategy because they are scum. FSI is trying to use debt to wipe out all existing shareholders. This is a typical tactic in these Chapter 11's. It makes sure people who own the debt will make off with all the equity and leave common shareholders holding the bag. This sort of stuff should be illegal. FSI just has to convince the creditors because they hold all the cards. And they usually go along with it because they are cut in on the deal. Freakin shameful.
0 · Reply
Mike909067777
Mike909067777 Jun. 29 at 12:56 AM
$SGMO so kiwi surfer after his usual trump bashing ( tds on steroids) now calls two long term holders short. That guy is a real piece of work I tell you I am glad his tds obsessed body stays in austrailia where it belongs He must be real fun at a party.
1 · Reply
IberianBullish
IberianBullish Jun. 28 at 11:06 PM
$SGMO Yep!!
0 · Reply
JimiJoJeeter
JimiJoJeeter Jun. 28 at 9:42 PM
$SGMO Ok...I'll admit they may have created an atmosphere consistent with causing the bidding war I expected when I called for public sale over a year ago, but I remain bearish for stockholders till they....
1 · Reply
MakingMoneyHere
MakingMoneyHere Jun. 28 at 6:46 PM
$SGMO It would be surprising if Sanofi didn't try to buy it.
1 · Reply
TGTT888
TGTT888 Jun. 28 at 6:45 PM
$SGMO The CEO would never have opted for Chapter 11 if he weren't going to profit massively from it. Again, the choice was his. He is now going to reap huge gains himself, and his options that kick in above 26 cents will become extremely valuable.
2 · Reply
Latest News on SGMO
No data available.
Herr_Chicken
Herr_Chicken Jun. 29 at 2:54 AM
$SGMO Listened to the whole First Day hearing tape yesterday; some things that hit me: 1. Even in bankruptcy, Sangamo is being a drama queen. It's amazing. They wanted the judge to approve their sale procedures by June 30 (!), before the creditor's committee is even formed. They are completely out of cash on June 30, if I heard correctly. The attorney for the US Trustee was freaking about all this happening before she could get the creditor's committee together and also freaking about the DIP financer's motion to get its entire fee approved on Day 1 of the bankruptcy, calling it unprecedented on both counts. There were real problems about due process to creditors and other interested parties. The judge had problems with both those things too, so now we have a hearing on the bid procedures by mid-month (i.e., after creditors committee organizes) and the judge approved the DIP financer but only made fee on the first 10.5 mill final. (cont. in replies)
3 · Reply
Scooter0732
Scooter0732 Jun. 29 at 1:53 AM
$SGMO What I found interesting was the attorney for Lilly made it a condition precedent to the APA that the auction be held on Aug 4th. They want to shorten the DD period which is their strongest lever to suppress bidding. In a sense that’s cool that they care enough to want to steal it, but this kind of maneuver will not work if there’s a party mid-DD the board overseeing the bankruptcy estate will stretch the timeline a bit to allow them to participate, if there is such a party. The judge was non-committal and punted on the issue, the picture will become clearer after indicate bids are submitted in July.
1 · Reply
Scooter0732
Scooter0732 Jun. 29 at 1:31 AM
$SGMO FSI is merely a DIP lender who wanted to take the operating losses in the holdco to merge it with some other profitable business to take advantage of NOL. They wouldn’t buy any other assets. SGMO is getting liquidated anyway. This is literally irrelevant to anything and in the end they were rejected and Sangamo chose the other lender. It might prevent SGMO from merging or being wholly aquired so it’s cleaner to just to get a DIP lender in it for some interest, so the board overseeing the bankruptcy made the right call.
0 · Reply
pblegend66
pblegend66 Jun. 29 at 1:08 AM
@jlemx $SGMO That last part is what terrifies me. They are trying to go the loan-to-own strategy because they are scum. FSI is trying to use debt to wipe out all existing shareholders. This is a typical tactic in these Chapter 11's. It makes sure people who own the debt will make off with all the equity and leave common shareholders holding the bag. This sort of stuff should be illegal. FSI just has to convince the creditors because they hold all the cards. And they usually go along with it because they are cut in on the deal. Freakin shameful.
0 · Reply
pblegend66
pblegend66 Jun. 29 at 12:59 AM
@jlemx $SGMO That last part is what terrifies me. They are trying to go the loan-to-own strategy because they are scum. FSI is trying to use debt to wipe out all existing shareholders. This is a typical tactic in these Chapter 11's. It makes sure people who own the debt will make off with all the equity and leave common shareholders holding the bag. This sort of stuff should be illegal. FSI just has to convince the creditors because they hold all the cards. And they usually go along with it because they are cut in on the deal. Freakin shameful.
0 · Reply
Mike909067777
Mike909067777 Jun. 29 at 12:56 AM
$SGMO so kiwi surfer after his usual trump bashing ( tds on steroids) now calls two long term holders short. That guy is a real piece of work I tell you I am glad his tds obsessed body stays in austrailia where it belongs He must be real fun at a party.
1 · Reply
IberianBullish
IberianBullish Jun. 28 at 11:06 PM
$SGMO Yep!!
0 · Reply
JimiJoJeeter
JimiJoJeeter Jun. 28 at 9:42 PM
$SGMO Ok...I'll admit they may have created an atmosphere consistent with causing the bidding war I expected when I called for public sale over a year ago, but I remain bearish for stockholders till they....
1 · Reply
MakingMoneyHere
MakingMoneyHere Jun. 28 at 6:46 PM
$SGMO It would be surprising if Sanofi didn't try to buy it.
1 · Reply
TGTT888
TGTT888 Jun. 28 at 6:45 PM
$SGMO The CEO would never have opted for Chapter 11 if he weren't going to profit massively from it. Again, the choice was his. He is now going to reap huge gains himself, and his options that kick in above 26 cents will become extremely valuable.
2 · Reply
jlemx
jlemx Jun. 28 at 6:34 PM
$SGMO he says that a FSI submitted a last minute competing DIP proposal and also indicated their interest in acquiring 100% of the equity. Who is this FSI?
2 · Reply
TGTT888
TGTT888 Jun. 28 at 5:47 PM
$SGMO Interest is surging following the FDA's confirmation in May that no new study is required; the Fabry product is becoming highly sought-after. Bids on July 25 should be at least in the $250–300 million range. I believe Takeda and Sanofi could go as high as $500 million. Astellas has the final say—that is what the contract stipulates—so it is possible that Astellas might exceed that figure.
3 · Reply
Dirtymartini66
Dirtymartini66 Jun. 28 at 4:54 PM
$SGMO has filed for bankruptcy and will sell its assets. The biotechnology company announced a pair of deals Tuesday that could hand certain gene editing tools as well as an experimental prion disease treatment to Eli Lilly, and a Fabry disease therapy that's nearing regulatory approval to Astellas Pharma. Lilly and Astellas will serve as lead bidders in a court-supervised auction that will also involve other Sangamo assets, such as experimental cell therapies and gene editing treatments for chronic pain and hemophilia
1 · Reply
Dirtymartini66
Dirtymartini66 Jun. 28 at 4:52 PM
$SGMO well folks - we should be hearing shortly what happens with the bids https://finance.yahoo.com/healthcare/articles/sangamo-holds-bankruptcy-sale-vcs-081200791.html
1 · Reply
rjalagam9111
rjalagam9111 Jun. 28 at 12:49 PM
$SGMO looks like BK was orchestrated by BP’s with insider information by holding back deals. If the products are no good, why they care about stock horse bids ? They have bought numerous companies paying top price. Why not buy Sangamo at fair price?
1 · Reply
Wischmop
Wischmop Jun. 28 at 5:06 AM
$SGMO That’s not to say there will actually be a payout for shareholders in the end—even though I’m counting on it and won’t cash out until I know the outcome. But I would personally be delighted if the case against Lilly fails and some of those bloated executives get run out of town in disgrace for being stupid enough to miss out on the opportunity of a lifetime. I hope those eggheads are already starting to sweat a little.
1 · Reply
Wischmop
Wischmop Jun. 28 at 4:59 AM
$SGMO "This does not mean that any sort of shady dealing is going on or that a fait accompli has already been established. The technology is of no use to Lilly unless it secures the know-how of key personnel; therefore, holding preliminary discussions with them is a legitimate move. By the same token, this implies that their planning is well advanced and that this is not an auction they intend to lose. Should other bidders emerge—and they will—the price will simply rise until Lilly wins the bid. The competition is not limited to mid-sized firms; it includes major players who risk missing out on a massive new market or, worse yet, losing their own market share. For shareholders, these arrangements are a positive development: they reduce liabilities by eliminating the need for severance payments—which would likely be substantial—that had previously been factored into the cost."
1 · Reply
JasonRKT
JasonRKT Jun. 27 at 11:54 PM
$SGMO end price $0.45 per share believe it or not.
2 · Reply
jlemx
jlemx Jun. 27 at 6:54 PM
$SGMO There are rumors of offers being made to employees by bidders; is this legal? After all, it could skew the auction to the detriment of other participants. It looks like a case of a buyer wanting to snap up a product on the cheap while simultaneously rewarding the SGMO employees who will stay on to complete the development of the Fabry disease treatment. It strikes me as a lack of transparency in the auction process. Have I understood this correctly?
3 · Reply
Nichdan
Nichdan Jun. 27 at 1:14 AM
$SGMO Clovis…I shouldn’t own another bio. Ever.
0 · Reply
kiwiSurfer
kiwiSurfer Jun. 26 at 11:27 PM
$SGMO one can only surmise both Scooter and Franca are both shorts and have been systematically sheparding the stock price to the gutter. Like Martin ( you know him his last name starts with S) or Trump there is a special place in hell for those obsessed with money over morality. Try reading the bible even…
2 · Reply
joe77w
joe77w Jun. 26 at 9:23 PM
$SGMO SGMO pipeline + agreements should be worth much more than 75/100 mln USD,only time Will tell... What I don't like, if Fabry partnered out of Ch11, co perhaps could have got the much needed liquidity to operate as a going concern while waiting approval and commercialization. Hemophilia A another good asset imo. I Hope Court to recognize the huge value this pipeline does have,not only for the benefit of creditors but for doctors patients and shareholders too. I Hope equityholders to retain some ownership In a new Sangamo or being liquidated some Money, .50 would equate 200 mln USD,too much? It Is only speculation,lets Hope 75/100 mln USD currently offered to become twice, other offers for left pipeline, if assets monetized reach 200/300 mln USD equityholders would receive some money back, liabilities not more than 140 mln USD DIP included, or not? Lets Hope new offers coming in next weeks. This Is a very High risk bet. This Is not a financial advice. Take care of your Money.
2 · Reply